The FDA released an updated guidance document for industry in March 2020 that focused on the safety of drugs for chronic use to improve glycemic control in T2DM patients (( 2020 fda.gov
Furthermore, each increase in apoA-IV concentrations of 10 mg/dL, was associated with a 40% lower risk to die when using the age-, sex- and kidney function-adjusted model 1 (HR = 0.60, 95%CI 0.430.85, p = 0.003)
As of 2021, an estimated 537 million people globally have diabetes
The rationale for this expanding interest and use of plant based treatments being that a significant proportion of hypertensive patients do not respond to Modern therapeutic medication

A biochemical and chemical technology, applied in the field of recombinant polypeptide preparation, can solve the problems of low yield, unfriendly environment and high cost Pending Publication Date: 2021-08-20 View PDF1 Cites 2 Cited by Summary Abstract Description Claims Application Information AI Technical Summary This helps you quickly interpret patents by identifying the three key elements: Problems solved by technology Method used Benefits of technology Problems solved by technology Since the synthesis of the polypeptide main chain mainly adopts the solid-phase method in the preparation process, a large amount of organic solvents are required, which is not friendly to the environment At the same time, this chemical synthesis method also has problems such as low yield and high cost in the preparation of long-chain polypeptides
Zur Untersttzung des Atmungssystems